Article Versions Notes

Rodríguez Hermosa JL, Vargas Centanaro G, González Castro ME, Miravitlles M, Lázaro-Asegurado L, Jiménez-Rodríguez BM, Rodríguez RA, Moreno Méndez R, Torres-Duran M, Hernández-Pérez JM, et al. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study. Biomedicines. 2023; 11(2):516. https://doi.org/10.3390/biomedicines11020516

Rodríguez Hermosa, Juan Luis, Gianna Vargas Centanaro, María Estela González Castro, Marc Miravitlles, Lourdes Lázaro-Asegurado, Beatriz María Jiménez-Rodríguez, Rosanel Amaro Rodríguez, Rosaly Moreno Méndez, María Torres-Duran, José María Hernández-Pérez, and et al. 2023. "Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study" Biomedicines 11, no. 2: 516. https://doi.org/10.3390/biomedicines11020516

Rodríguez Hermosa, J. L., Vargas Centanaro, G., González Castro, M. E., Miravitlles, M., Lázaro-Asegurado, L., Jiménez-Rodríguez, B. M., Rodríguez, R. A., Moreno Méndez, R., Torres-Duran, M., Hernández-Pérez, J. M., Humanes-Navarro, A. M., & Calle Rubio, M. (2023). Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study. Biomedicines, 11(2), 516. https://doi.org/10.3390/biomedicines11020516